CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Zenith(R) Fenestrated AAA Endovascular Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00875563
NCT00875563N/ACompleted
CompareCT.gov

Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft

Cook Group Incorporated·interventional·Posted Apr 3, 2009·Updated Jan 11, 2017

In Brief

A clinical study evaluating Zenith(R) Fenestrated AAA Endovascular Graft for Abdominal Aortic Aneurysms and 2 related conditions. Completed, enrolled 42 participants across 14 sites.

Detailed Summary

The Zenith(R) Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Aortic Aneurysms, Aorto-iliac Aneurysms, Juxtarenal Aneurysms
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 3, 2009
Enrollment StartJan 1, 2005
Primary CompletionFeb 1, 2011
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 17.2 years ago

Interventions

Zenith(R) Fenestrated AAA Endovascular Graftdevice

The Zenith(R) Fenestrated AAA Endovascular Graft with the H\&L-B One-Shot™ Introduction System is indicated for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms having morphology suitable for endovascular repair